发明名称 APPLICATION OF HYPOGLYCEMIC AGENT FOR TREATING AFFECTED GLUCOSE METABOLISM
摘要 FIELD: medicine. ^ SUBSTANCE: application of hypoglycemic agent as nateglinide for treating affected glucose metabolism for the purpose to prevent or deteriorate the onset of pronounced non-insulin dependent diabetes mellitus or prevent or deteriorate the onset of other manifestations of affected glucose metabolism. The innovation proves nateglinide's capacity to restore early phase of insulin secretion, that is it should be applied as an intensifier of insulin secretion. ^ EFFECT: higher efficiency of application. ^ 7 cl, 5 ex, 1 tbl
申请公布号 RU2264811(C2) 申请公布日期 2005.11.27
申请号 RU20020119558 申请日期 2000.12.04
申请人 发明人 GITAR KRISTIAN;MJULLER BEATE;EHMMONS REBEKKA
分类号 A61K45/00;A61K31/195;A61K31/198;A61K31/216;A61K31/427;A61K31/4453;A61K31/55;A61K31/64;A61P3/04;A61P3/06;A61P3/10;A61P5/50;A61P7/00;A61P9/00;A61P9/10;A61P9/12;A61P13/12;A61P25/00;A61P27/02;A61P35/00 主分类号 A61K45/00
代理机构 代理人
主权项
地址